• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
EZZ
Click for more information
0.60% 84.5¢

EZZ LIFE SCIENCE HOLDINGS LIMITED

Market Cap $37.52M  ! watchlist Created with Sketch. Add to my watchlist
Technology Scientific & Technical Instruments

EZZ Life Sciences (ASX:EZZ) is a genomic life sciences company with a mission to improve... EZZ Life Sciences (ASX:EZZ) is a genomic life sciences company with a mission to improve quality of life and human health. EZZ has a focus on genomic research and development to address four key human health challenges: genetic longevity, human papillomavirus (HPV), helicobacter pylori, and weight management.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
EZZ
Ann: EZZ Completes Private Placement with Strategic Investor 		16/04/24 22 3.2K
16/04/24 Last post  Alex19856 Comments Created with Sketch.  22  Views Created with Sketch.  3.2K 
EZZ
Ann: Notice under Section 708A(5)(e) of the Corporations Act 2001 		15/04/24 0 111
15/04/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  111 
EZZ
Ann: Application for quotation of securities - EZZ 		15/04/24 0 108
15/04/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  108 
EZZ
Ann: Proposed issue of securities - EZZ 		12/04/24 0 141
12/04/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  141 
EZZ
Ann: Investor Presentation 1H FY24 and Market Update 		11/04/24 39 7.0K
11/04/24 Last post  Mo1983 Comments Created with Sketch.  39  Views Created with Sketch.  7.0K 
EZZ
News: EZZ Ezz Life Science Posts HY Revenue A$21.7M 		27/03/24 0 127
27/03/24 Last post  Hot News Comments Created with Sketch.  0  Views Created with Sketch.  127 
EZZ
Ann: Half Yearly Report and Accounts 		27/03/24 20 3.7K
27/03/24 Last post  Clivus Comments Created with Sketch.  20  Views Created with Sketch.  3.7K 
EZZ
Ann: Quarterly Activities/Appendix 4C Cash Flow Report 		28/02/24 36 7.3K
28/02/24 Last post  ReverY Comments Created with Sketch.  36  Views Created with Sketch.  7.3K 

See All Discussions arrow Created with Sketch.

Timeline

Notice under Section 708A(5)(e) of the Corporations Act 2001
15 Apr 14:44
 
Application for quotation of securities - EZZ
15 Apr 14:36
 
Proposed issue of securities - EZZ
12 Apr 09:08
 
EZZ Completes Private Placement with Strategic Investor
12 Apr 09:04
 
Investor Presentation 1H FY24 and Market Update
27 Mar 09:02
 
Half Yearly Report and Accounts
29 Feb 13:28
 
View More arrow Created with Sketch.

Featured News

OZM OzAurum Resources ups the ante on the charge for lithium in Brazi
right-arrow Created with Sketch.
LGP Little Green Pharma heading into Q2 cashed up after record sales
right-arrow Created with Sketch.
BGD Barton kicks off scoping studies at Tunkillia – a 1.5Moz gold play
right-arrow Created with Sketch.
TLX Telix Pharmaceuticals granted US-FDA fast track designation for brain cancer detection
right-arrow Created with Sketch.
NEWS Chris Judd's Talk Ya Book: Furnishing a short position on TPW
right-arrow Created with Sketch.
RCE Recce Pharmaceuticals up on new antibiotic production milestone
right-arrow Created with Sketch.
(20min delay)
Last
84.5¢ 		Change
0.005(0.60%) 		Mkt cap ! $37.52M
Open High Low Value Volume
85.0¢ 85.0¢ 82.0¢ $14.06K 16.56K

Buyers (Bids)

No. Vol. Price($)
1 8000 83.0¢
 

Sellers (Offers)

Price($) Vol. No.
84.5¢ 10199 1
View Market Depth
Last trade - 15.51pm 18/04/2024 (20 minute delay) ?
EZZ (ASX) Chart

Top Stories

Market Update: Energy keeps light bright in a sea of red

The ASX is down .7 of a per cent with every sector - except energy - in the red and real estate diving nearly 2 per cent mid-session.
Recce Pharmaceuticals up 6% on new antibiotic production milestone Recce Pharmaceuticals (ASX:RCE) is trading up more than 6 per cent after producing a 5000-dose batch of its new antibiotic RECCE 327 (R327) under Good Manufacturing Practises (GMP) standards.
Chariots of fire on pole to meet resurgent US lithium security focus. Chariot Corporation is a company in a hurry.Since listing on the Australian stock exchange (ASX) in October, Chariot’s focus has been on building up a significant suite of lithium projects across three US states with the goal of securing future supply of the mineral to fulfil a vo...
Week 15 Wrap: USA uncertain, ECB shrugs at the Fed & gold, gold, gold Depending on what interests you more, there were two big stories this week for the international finance space.
Canada's Hillcrest Energy (CSE.HEAT) partners with BC's Powertech Labs Canada-based Hillcrest Energy Technologies has teamed up with British Columbia-based Powertech Labs to test Hillcrest's ZVS technology.

Featured News

TLX Telix Pharmaceuticals granted US-FDA fast track designation for brain cancer detection
right-arrow Created with Sketch.
RDN Raiden rolls up heritage work at twin Pilbara lithium plays
right-arrow Created with Sketch.
FXG Market purrs with approval of Felix's 90% gold recovery in Alaska
right-arrow Created with Sketch.
NEWS Week 15 Wrap: USA uncertain, ECB shrugs at the Fed & gold, gold, gold
right-arrow Created with Sketch.
RCE Recce Pharmaceuticals up on new antibiotic production milestone
right-arrow Created with Sketch.
BGD Barton kicks off scoping studies at Tunkillia – a 1.5Moz gold play
right-arrow Created with Sketch.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.